Bengaluru, India

Rahul Malviya

This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Carefusion 303, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rahul Malviya. Retrieved from https://idiyas.com/inventor/rahul-malviya-v7n1em1z

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rahul Malviya: Inventor of an Infusion-Set Flow Regulation Clamp

Introduction

Rahul Malviya is an inventor based in Bengaluru, India. His patent work includes a device designed to regulate fluid flow in an infusion set.

Latest Patents

Malviya is associated with 1 patent: “Stable IV Flow Regulation Clamp Assembly.” The invention describes a clamp assembly that adjusts the fluid flow rate through an infusion-set connector tube. It includes a housing that receives the tube, a sliding component that compresses it to adjust flow, and a rotator knob that moves the slider. The patent also addresses infusion sets and methods for adjusting fluid flow rates.

Career Highlights

Malviya has worked with CareFusion 303, Inc. and Becton Dickinson and Company Limited. His patent reflects work on a practical component for controlling fluid delivery in infusion systems.

Collaborations

His listed coworkers include Amarsinh Deeliprao Jadhav and Narsi Reddy Sanikommu.

Conclusion

Rahul Malviya’s patent focuses on a stable, adjustable clamp assembly for regulating fluid flow in infusion sets, connecting his inventive work with medical-device development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…